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ARTICLE
Severe neurodegenerative disease in brothers with
homozygous mutation in POLR1A
Bülent Kara1,11, Çiğdem Köroğlu2,11, Karita Peltonen3, Ruchama C Steinberg4, Hülya Maraş Genç1,
Maarit Hölttä-Vuori5,6, Ayşe Güven2, Kristiina Kanerva5,6, Tuğba Kotil7, Seyhun Solakoğlu7, You Zhou6,8,
Vesa M Olkkonen5,6, Elina Ikonen5,6, Marikki Laiho3,9,10 and Aslıhan Tolun*,2
In two brothers born to consanguineous parents, we identiﬁed an unusual neurological disease that manifested with ataxia,
psychomotor retardation, cerebellar and cerebral atrophy, and leukodystrophy. Via linkage analysis and exome sequencing, we
identiﬁed homozygous c.2801C4T (p.(Ser934Leu)) in POLR1A (encoding RPA194, largest subunit of RNA polymerase I) and
c.511C4T (p.(Arg171Trp)) in OSBPL11 (encoding oxysterol-binding protein-like protein 11). Although in silico analysis,
histopathologic evidence and functional veriﬁcation indicated that both variants were deleterious, segregation with the patient
phenotype established that the POLR1A defect underlies the disease, as a clinically unaffected sister also was homozygous for
the OSBPL11 variant. Decreased nucleolar RPA194 was observed in the skin ﬁbroblasts of only the affected brothers, whereas
intracellular cholesterol accumulation was observed in the skin biopsies of the patients and the sister homozygous for the
OSBPL11 variant. Our ﬁndings provide the ﬁrst report showing a complex leukodystrophy associated with POLR1A. Variants in
three other RNA polymerase subunits, POLR1C, POLR3A and POLR3B, are known to cause recessive leukodystrophy similar to
the disease afﬂicting the present family but with a later onset. Of those, POLR1C is also implicated in a mandibulofacial
dysostosis syndrome without leukodystrophy as POLR1A is. This syndrome is absent in the family we present.
European Journal of Human Genetics advance online publication, 4 January 2017; doi:10.1038/ejhg.2016.183
INTRODUCTION
Three mammalian polymerases, RNA polymerases (Pol) I, II and III,
transcribe the major classes of RNAs: the ribosomal, messenger and
transfer RNAs. Of these, Pol I transcribes the 47S precursor rRNA that
is processed to the mature 28S, 18S and 5.8S rRNAs. Pol I
transcription is the critical rate-limiting step in ribosome biogenesis.
The transcription is compartmentalized to the nucleolus and attunes
to the critical needs of protein synthesis during cell growth, division
and differentiation.1–3 Defects in three subunits of Pol III, namely,
POLR1C (shared by Pol I), POLR3A and POLR3B, have been
associated with recessive hypomyelinating leukodystrophy.4–6 Defects
in Pol I complex subunits POLR1A, POLR1C and POLR1D cause
craniofacial anomalies consistent with perturbed ribosome
biogenesis.7,8
Leukodystrophies are heterogeneous disorders that primarily affect
the white matter and are associated with anomalies of glial cells and
myelin sheath.9 They are classiﬁed as hypomyelinating and demyeli-
nating according to MRI results. The two brothers born to con-
sanguineous Turkish parents we present here have cerebellar ataxia
associated with spasticity, intellectual disability, cerebellar and cerebral
atrophy, and demyelinating leukodystrophy. Candidate loci were
found by linkage analysis, and homozygous variants in POLR1A and
OSBPL11 were identiﬁed by exome sequencing. An unaffected sister
was homozygous for the OSBPL11 variant but did not carry the
POLR1A variant. The POLR1A defect was veriﬁed to be pathogenic by
molecular modelling studies and functional assays. These ﬁndings
constitute the ﬁrst report showing a leukodystrophy syndrome
associated with POLR1A, encoding RPA194, catalytic subunit of
RNA polymerase I.
SUBJECTS AND METHODS
Family
The parents were half-ﬁrst cousins once removed, with two affected sons and
two healthy daughters (Figure 1). The study was conducted in accordance with
the Declaration of Helsinki and national guidelines. Informed consent was
obtained from/for participants in accordance with the regulations of the
Boğaziçi University Institutional Review Board for Research with Human
Participants that approved the study protocol.
Genetic analyses
Single-nucleotide polymorphism (SNP) genome scan was performed for the
siblings, and multipoint LOD scores were calculated assuming autosomal
recessive inheritance, initially with full penetrance and later with 70%
penetrance. All loci4200 kb and yielding LOD scores of42 were investigated
for homozygosity possibly identical by descent. In addition, regions of
homozygosity shared by the brothers only were searched using Homozygosity
Mapper. Exome of brother 1 was sequenced and data were evaluated as
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described in Supplementary Methods. Hg19 map was used throughout
the study.
RPA194 homologue structure, domains, and tertiary structure
prediction
The full-length human RPA194 (O95602) and S. cerevisiae A190 (P10964)
sequences were identiﬁed and divided into three sections, based on their
predicted domain architecture, for submission to tertiary structure predictions.
Yeast A190 was used as a control for the accuracy of the tertiary structure
prediction programs as compared with the solved structure.10,11 Domain
architecture predictions were made via Pfam, PROSITE, SMART and the
CDD. The residue of interest, Ser934, locates to the middle section of RPA194
that we will refer to as RPA194_Segment2. The sequences of RPA194_Seg-
ment2 and A190_Segment2 were submitted for tertiary structure prediction via
Phyre2.12 All tertiary structure predictions were subjected to evaluation using
ProSAweb and Verify3D.13,14 Models were then ranked by these results, and the
best model for RPA194_Segment2 was selected for further analysis. Solved
structures of yeast A190 were submitted for model evaluation as control.
PyMOL was used to visualize the best model and the solved structure 4c2m.
Using PyMOL, the human RPA194_Segment2 was superimposed with the
solved structures of yeast A190. Ser934 was then mutated to Leu using the
PyMOL mutagenesis tool. PyMOL distance measurement tool was used to
assess possible interactions between RPA194 and RPA135 (A127 in yeast) based
on the prediction of interactions described in 4c2m.
Cell culture
Fibroblast cultures were established from skin biopsies of the father and sons.
Control ﬁbroblast cell lines AG08498 and GM0323 were obtained from Coriell
Institute for Medical Research (Camden, NJ, USA), and F92-99 has been
described previously.15 Fibroblast cell cultures were maintained in Eagle’s
minimum essential medium supplemented with 15% FBS, 2 mM L-glutamine,
100 IU/ml penicillin and 100 μg/ml streptomycin.
Immunoﬂuorescence microscopy and image analysis
Fibroblasts grown on coverslips were ﬁxed in 3.5% PFA, permeabilized with
0.5% NP-40 and blocked in 3% BSA. The primary antibodies used were
RPA194 (C-1, Santa Cruz Biotechnology, Santa Cruz, CA, USA) and FBL
(ab582, Abcam, Cambridge, MA, USA). Secondary Alexa488 and Alexa594-
conjugated anti-mouse and anti-rabbit antibodies were from Invitrogen
(Carlsbad, CA, USA). DNA was stained using DAPI. Images were captured
using Leica DM6000B ﬂuorescence wide-ﬁeld microscope equipped with
Hamamatsu Orca-Flash sCMOS camera, 20× objective (20× /0.7 HC PL
APO CS, Leica, Wetzlar, Germany) and LasX software (Leica). Image analysis
was conducted using FrIDA software as described previously.16 An average of
100 cells were quantiﬁed from two ﬁelds for each sample.
Figure 1 The pedigree and cranial MR images. DNA samples subjected to SNP genotyping are indicated by * on the pedigree, and those for variant testing
are indicated by +. POLR1A and OSBPL11 variant genotypes are given. MR images of the brothers revealed enlarged ventricles, cortical sulci and
subarachnoid spaces indicative of cerebral atrophy, diffuse hyperintense involvement of periventricular white matter extending to subcortical white matter,
atrophy of the cerebellar hemispheres and the vermis, and thin corpus callosum. Brother 2 has additionally a subarachnoid cyst in the left posterior fossa.
The sisters have normal MRI ﬁndings. Parents have normal white matter and very mild cerebral atrophy. (a) Axial T2 weighted. (b) Coronal T2 weighted.
(c) Sagittal T1 weighted.
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Filipin staining of skin biopsy samples
Skin samples were obtained from the two patients, sister 2 (202 in Figure 1)
and the parents via punch biopsy, and 5-μm thick cryosections were ﬁxed in
2.5% glutaraldehyde and 2% paraformaldehyde (PFA) in phosphate-buffered
saline (PBS) solution. Skin cryosections provided by the Medical Faculty of
Istanbul Pathology Department were used as controls. Sections were stained for
2 h at room temperature in a mixture that contained 1 ml of fetal bovine serum
(FBS), 9 ml of PBS and 20 μl of ﬁlipin (Sigma, St Louis, MO, USA F9765)
solution (5 mg/ml in DMSO). Slides washed in PBS were viewed under a
ﬂuorescent microscope (Leitz Wetzlar) using ultraviolet light with excitation of
340–380 nm and emission of 385–470 nm to observe free (unesteriﬁed)
cholesterol. Photographs were obtained using 4 s exposures at a magniﬁcation
of × 320.
RESULTS
Clinical ﬁndings
According to their parents, the affected brothers had uneventful
prenatal and natal histories and were born at term. They were
small for gestational age and with relative macrocephaly. They had
psychomotor retardation. For brother 1 (203 in Figure 1) ataxic
gait was evident at age 5 years, and he became non-ambulatory at
age 9.5 years. Brother 2 (204) never achieved head control, sat
unsupported, walked or spoke. He began having seizures at the age
of 6 years.
The brothers were referred together to the medical school with
complaints of abnormal gait/inability to walk and intellectual
disability. At presentation, they had relative macrocephaly and
normal weight, but younger brother 2 was short (o3rd p). The
clinical ﬁndings were similar in both and are compiled in Table 1.
The brothers had intellectual disability but no autistic features.
Physical examination showed truncal ataxia, head titubation and
spasticity. Muscle tonus was increased, especially in the lower
extremities. Deep tendon reﬂexes were hyperactive. Achilles clonus
and Babinski sign were positive. Achilles tendons were tight, and
bilateral equine deformity was evident. Horizontal and vertical eye
movements were normal at the initial visit but became limited in
the 5-year follow-up, more prominent for brother 2. The meta-
carpophalangeal joints, elbows and distal phalanges of the ﬁngers
were hyperextensible. In addition, brother 1 had developed thenar
atrophy of the hands, ﬂexion deformity of the left hand and
bilateral pes cavus deformity. Brother 2 could not control his head,
walk or speak but could sit with support. Whole blood and urine
analyses were normal in both brothers. Both had bilateral optic
atrophy, but hearing was normal. Motor nerve conduction studies
were normal for brother 2, but in brother 1 distal latencies were
prolonged in the peroneal and tibial nerves, with normal com-
pound muscle action potential amplitudes. In both brothers,
sensory nerve conduction studies were normal. Cranial MRI
indicated cerebral atrophy, diffuse white matter hypointensity at
T1-weighted images and hyperintensity at T2-weighted images
compatible with demyelinating leukodystrophy, severe atrophy of
the inferior cerebellar vermis and moderate atrophy of both the
superior cerebellar vermis and cerebellar hemispheres, mega
cisterna magna and a thin corpus callosum (Figure 1). Brother 2
had in addition a posterior fossa arachnoid cyst on the left side,
without any signs of pressure; thus, the cyst was considered an
incidental ﬁnding. 3D cranial CT scans performed recently did not
show any sign of mandibulofacial dysostosis (Supplementary
Figure 1). The clinical ﬁndings in full are in Supplementary
Information. Neurologic examination was normal in the sisters
and parents, but cranial MRI results showed very mild cerebral
atrophy in the parents (Figure 1).
Genetic ﬁndings
In linkage analysis assuming either full or 70% penetrance not to miss
any possible candidate variant with reduced penetrance, the maximal
LOD scores were 2.65 and 2.05, respectively, both lower than the
critical value 3, because of small family size (Supplementary Figure 2).
No additional candidate locus was found by homozygosity mapping.
At each locus haplotype segregation analysis was applied to investigate
whether the homozygosity that the patients shared was possibly due to
identity by descent. A maximal LOD score of 0.3 excluded X-linked
inheritance.
As no clinical phenotype similar to that in our patients was reported
on the OMIM Phenotype Map (NCBI Map Viewer) at the candidate
loci (Supplementary Table 1), we proceeded with exome sequencing
(Supplementary Methods). Those loci together harboured two novel
or rare variants that were predicted to affect protein structure
(Supplementary Table 1; see Supplementary Figure 3 for Sanger
validation). POLR1A NM_015425.3 c.2801C4T (p.(Ser934Leu)) was
novel, whereas dbSNP138 listed OSBPL11 NM_022776.4 c.511C4T
(p.(Arg171Trp)) as rs370760880. The variants were not found in the
tested 398 or 278 Turkish control samples, respectively. OSBPL11
variant was recently found in a new individual in the Turkish Exome
Database (Bayram Yüksel, personal communication), raising the
population frequency to ∼ 0.0005, and is reported in ExAC database
in only Europeans and South Asians, with a frequency of 0.00004.
Three prediction algorithms were utilized to investigate the effects
of the variants on protein function. Mutation Taster predicted both
variants as damaging.17 PolyPhen-2 predicted OSBPL11 c.511C4T
(p.(Arg171Trp)) as damaging and POLR1A c.2801C4T (p.(Ser934-
Leu)) as benign; in contrast, SIFT predicted the former variant as
tolerated and the latter as damaging.18,19 In both variants the altered
residues were conserved across species (Supplementary Figure 4).
POLR1A c.2801C4T (p.(Ser934Leu)) results in the substitution of
polar serine by nonpolar leucine at position 934 in RPA194. The
residue is within a region of 104 amino acids that are conserved in full
among all mammals. In addition, the region adjacent to the residue
is highly conserved even in lower eukaryotes. OSBPL11 c.511C4T
(p.(Arg171Trp)) leads to the substitution of positively charged,
hydrophilic arginine with nonpolar, hydrophobic tryptophan at
position 171 in the 747 amino-acid protein. Arg171 is located in a
stretch of 116 amino acids that are fully conserved in mammals
and highly conserved among vertebrates. The substitution could
limit the protein’s function because of a change in the three-
dimensional structure, the loss of a hydrophilic functional residue
and/or the lack of phosphorylation at the adjacent serine residue.20
Together, these ﬁndings suggest that both variants are potentially
deleterious. Of note, the affected brothers were homozygous for
both variants, whereas sister 2 (202) was homozygous for the
OSBPL11 variant but did not carry the POLR1A variant (Figure 1).
Thus, POLR1A c.2801C4T (p.(Ser934Leu)) is identiﬁed as the
cause of the severe neurologic phenotype in the two brothers.
Whether the deleterious OSBPL11 variant contributes to the
complex clinical manifestations in the family can be discerned
when new families with OSBPL11 mutations are detected.
Dissection of the role of POLR1A p.Ser934Leu
Predicted effects on protein structure. POLR1A encodes RPA194, the
largest, catalytic subunit of the Pol I core complex. Two high-
resolution crystal structures have provided detailed information
on the interactions and functional roles of the subunits.10,11
RPA194 interfaces with RPA135 (encoded by POLR1B), forming
the composite active site of the enzyme. These subunits also form
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the horseshoe-shaped framework conserved among Pols I, II and
III. Based on the Pol I crystal structure in yeast, the region around
the variant forms the enzyme funnel and one of the interaction
faces with RPA135.10,11
To assess the potential impact of the variant on the protein–
protein (RPA194-RPA135) interaction, we ﬁrst superpositioned
human RPA194 on the yeast A190 crystal structure11 and used
several molecular modelling tools for the prediction of the folding
of the human RPA194, and conducted several tertiary structure
predictions. We modelled RPA194_Segment2 containing residues
616–1287 that consists of the pore domain, the funnel domain in
which the residue of interest lies, the cleft domains containing both
the trigger loop and the bridge helix and the foot domain.
Superimposition of RPA194_Segment2 with 4c2m solved structure
of yeast A190 produced a RMSD score of 0.744, indicating that
there is a high degree of similarity in the folding and secondary
structure of both the structured and unstructured regions in the
RPA194 interaction domain with RPA135 (Figure 2a). Based on
the sequence alignment of yeast A190 to human RPA194, amino
acids Ser931, Lys933 and Pro936 in the vicinity of the altered
residue Ser934Leu are predicted to interact with A127 (the yeast
RPA135 subunit; Figure 2b). In this model, Ser934 is located in the
Table 1 Characteristics of the family members
Features Brother 1 (203) Brother 2 (204) Sister 1 (201) Sister 2 (202) Father (101) Mother (102)
Age (years) 11 6.5 24 19 45 45
Postnatal history
Low birth weight + + − − − −
Hypoglycaemia in newborn − + − − − −
Relative macrocephaly + + − − − −
Neurologic development
Head control + − + + + +
Sitting + − + + + +
Walking − − + + + +
Speech Single word − + + + +
Mental retardation Severe Severe − − − −
Normal development − − + + + +
Developmental regression + − − − − −
Seizures − + − − − −
Physical examination
Truncal ataxia + + − − − −
Head titubation + + − − − −
Pyramidal signs + + − − − −
Joint hyperextensibility + + − − − −
Pes cavus + − − − − −
Equinism + − − − − −
Skin ﬁndings − − − − − −
Short stature − + − − − −
Eye examination
Bilateral optic atrophy + + NA NA NA NA
Gaze palsy + + − − − −
Nerve conduction studies
Motor nerves Prolonged distal latencies; normal CMAP N NA NA NA NA
Sensory nerves N N NA NA NA NA
Cranial MRI ﬁndings
Cerebral atrophy + + − − + −
White matter involvement + + − − − −
Cerebellar atrophy + + − − + +
Posterior fossa arachnoid cyst − + − − − −
Thin corpus callosum + + − − − −
Thick corpus callosum − − + + + +
3D cranial CT N N NA NA NA NA
Skin biopsy
Cholesterol storage + + + + NA + + + +
Abbreviations: N, normal; NA, not analysed.
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intramolecular side of RPA194. Two residues were identiﬁed to be
within range to interact with the residue at 934. Pro522 in A127
forms a nonbonding contact with Ser934, and this interaction does
not change upon substitution with a leucine (Figure 2c). The
Ser934Leu substitution brings the leucine methyl groups in close
vicinity (1.6 Å) of RPA194 Ala947, raising the potential for its
intramolecular interaction (Figure 2d).
Decreased amount of nucleolar RPA194 in patient cells. We used
ﬁbroblasts isolated from the two affected brothers, the father and
unrelated controls to assess the subcellular distribution of RPA194.
The cells were stained for RPA194 and ﬁbrillarin (FBL), a nucleolar
protein that modiﬁes the newly synthesized rRNA, and conducted
quantitative image analysis for the staining intensities of the proteins.
Nucleolar RPA194 was found to be markedly reduced in both patients
compared with the controls and the father. Nucleolar FBL was also
decreased in brother 2 (Figure 3). These results suggested that the
substitution compromises the ability of RPA194 to engage in its
nucleolar activities.
Putative role of OSBPL11 c.511C4T (p.(Arg171Trp)) in increased
cholesterol deposition
OSBPL11 was suggested to have a role an intracellular lipid
transport,21 and OSBPL proteins may be cooperating with the
NPC1 protein.22 We therefore hypothesized that an amino acid-
altering variant in OSBPL11 might result in a cellular pathology
similar to that in Niemann–Pick disease type C (NPC) disease and
could increase the severity of the disease in the family under study.
We stained dermal tissue specimens with the ﬂuorescent dye ﬁlipin
that binds free cholesterol. This histopathologic analysis revealed
bright ﬂuorescent droplets in the cytoplasm of the cells, predomi-
nantly in dermal ﬁbroblasts, indicative of free cholesterol accu-
mulation in affected brothers and sister 2 homozygous for
OSBPL11 c.511C4T (p.(Arg171Trp)), and mildly in heterozygous
parents (Figure 4). Such ﬂuorescently stained inclusions were
absent in the control preparations. However, no ﬁlipin-stainable
cholesterol deposition was observed in ﬁbroblasts cultured
from dermal biopsies of the brothers (Supplementary Figure 5).
This suggests that the cholesterol accumulation phenotype is
distinct from the cholesterol accumulation caused by loss of
NPC1 function. A putative functional impact of the OSBPL11
c.511C4T variant was further pursued in RNA interference/
phenotypic rescue experiments (Supplementary Figure 6,
Supplementary Methods and Supplementary Data). The results
demonstrated that a cholesterol deposition resulted speciﬁcally
from OSBPL11 silencing and transfection of OSBPL11-silenced
cells with the c.511C4T mutant 'but not with the wildtype' failed
to rescue the cholesterol deposition, suggesting that the variant
protein is functionally defective and unable to facilitate normal
cholesterol trafﬁcking.
DISCUSSION
We showed by functional studies that the homozygous POLR1A
variant we identiﬁed in the two brothers underlies the new
Figure 2 Molecular modelling of human RPA194 and its Ser934Leu variant. (a) Modelling of RPA194 based on yeast A190. The ribbon structures of
RPA194 (light blue) and A190 (dark blue) and the conserved Ser934 and Thr965 residues (both green) are shown. (b) The interface between RPA194 (light
blue) and A127 (grey) is shown and residues with predicted intermolecular interactions based on the crystal structure are shown in green and yellow.
(c, d) RPA194 (light blue) interface with A127 (grey) is shown alternatively with wild-type Ser934 (green, c) and mutant Leu934 (red, d). RPA194 Ala947
(orange) and A127 Pro522 (purple) predicted to interact with residue at 934 are shown. Note the shortened distance (1.6 Å) between the mutant Leu934
and RPA194 Ala947.
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demyelinating leukodystrophy associated with atrophy of the
cerebellum, cerebrum and corpus callosum. We thus deﬁne a
novel complex leukodystrophy and a new phenotype for POLR1A
defect. Recently, heterozygous variants in the gene were shown to
cause dominant acrofacial dysostosis type Cincinnati;7 however, we
found that the zygomatic, maxillary and mandibular bones of the
boys were normal. Neither the two sisters nor the parents have any
neurological signs, but the parents display very mild cerebral
atrophy.
With the recent advances in genotyping arrays and exome sequen-
cing, identiﬁcation of novel monogenic disease genes in small families
has become feasible. Although the currently most commonly applied
strategy for this task is exome sequencing of all siblings, we did not use
this approach, because we wanted to detect all loci possibly harbouring
fully penetrant candidate variants as well as those with low penetrance,
via linkage analysis. By evaluating exome data of one affected sib at
candidate disease loci followed by Sanger sequencing validation of
candidate variants, we found two missense homozygous candidate
variants, namely, POLR1A c.2801C4T and OSBPL11 c.511C4T, in
the two affected siblings of the study family. In functional analysis we
focussed on both variants and showed that both are possibly
deleterious. However, only the former segregated with the severe
phenotype. Neither of these genes has previously been associated with
a neurological disease.
Our data, molecular modelling and prediction models suggested
that the POLR1A Ser934Leu change leads to an alteration in
the conformation of the encoded RPA194 protein. The modelling
showed that Ser934 was located in an unstructured ﬂexible
domain that interacts with A127. This interaction is mediated by
amino acids in the immediate vicinity of Ser934, namely,
Ser931, Lys933 and Pro936, that protrude into the RPA135
domain. However, the modelling suggested that the Leu934
substitution may lead to a change in the intramolecular association
of RPA194, raising the potential that this would decrease
the ﬂexibility of the linker domain interacting with RPA135.
Subsequently, this could pose a challenge in the stability of the
RPA194–RPA135 interaction and localization, compromising the
Pol I transcription activity.
We further observed that the amount of RPA194 in the
nucleolus was decreased in skin ﬁbroblasts derived from the
patients. This is consistent with the modelling studies predicting
that the protein–protein interactions of mutant RPA194 may be
compromised. We speculate that this defect becomes a vulnerability
during times of development and growth when highly active Pol I
transcription is critically needed. POLR1C and POLR1D have been
implicated in recessive and dominant Treacher Collins syndrome,
respectively.8 This rare disease manifests at birth with mandibulofacial
dysostosis but normal intelligence. Recently, three heterozygous variants
Figure 3 Expression of RPA194 in patient and control ﬁbroblasts. (a) Immunostaining of RPA194 and ﬁbrillarin (FBL) in the patients, father and control
(AG for AG08498 and F9 for F92-99) ﬁbroblasts. Cells were ﬁxed and stained for RPA194 (green) and FBL (red), and counterstained for DNA (DAPI).
Merged images are shown to the right. Scale bar, 20 μm. (b) Image quantiﬁcation. Image analysis was conducted using FrIDA image analysis software for the
expression of RPA194 and FBL and normalized to DNA. The specimens were then compared with the average of the control ﬁbroblasts.
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in POLR1A, namely, c.1777G4C (p.(Glu593Gln)), c.3649delC
(p.(Gln1217Argfs*)) and c.3895G4T (p.(Val1299Phe)), were found
associated with acrofacial dysostosis type Cincinnati.7 The deduced
changes in the protein would locate to the RPA194 activation domain,
trigger loop and the jaw and cause severe, moderate and mild
dysostosis, respectively. Hypomorphic polr1a mutations introduced
to zebraﬁsh caused developmental defects including small, misshapen
heads, microphthalmia, cerebral hypoplasia, jaw agenesis and changes
in pigmentation and morphology of the heart. These ﬁndings and our
results here are suggestive that speciﬁc POLR1A variants potentially
cause broad multiorgan developmental defects, including the brain
and cerebellum. Importantly, the clinical phenotypes of our patients
show striking resemblance, except for the earlier onset, to Pol III-
related leukodystrophies resulting from variants in POLR1C, POLR3A
or POLR3B.4–6 Given that Pol III transcribes several noncoding RNAs,
most notably tRNAs but also ribosomal 5S RNAs and other small
nuclear, cytoplasmic and mitochondrial RNAs, the present ﬁndings
suggest that defects in noncoding RNA synthesis have the potential to
compromise development and cause complex cognitive and motor
disease syndromes. Considering also our ﬁndings, variants in only
Figure 4 Filipin staining of dermal tissue from the brothers, the sister homozygous for the OSBPL11 c.511C4T (p.(Arg171Trp)) variant (202), the parents
and a control sample. The samples of the sibs have free cholesterol-related ﬂuorescent staining in granular pattern (arrows) in dermal ﬁbroblasts interspersed
among collagen bundles and ground substance, whereas staining in parents’ tissues was less prominent. Granular staining of cholesterol was not observed in
the control dermal tissue.
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POLR1A and POLR1C are so far known to cause either leukodystro-
phy or mandibulofacial dysostosis. As the presented family is the ﬁrst
one with POLR1A-associated leukodystrophy, detection of new
families with POLR1A mutations will clarify the severity of the
phenotype.
Genetic defects of lipid metabolism often associate with neurode-
generative diseases. For an example, NPC is a rare, autosomal recessive
lysosomal cholesterol storage disease that causes progressive
neurodegeneration and visceral involvement with variable clinical
manifestations. The NPC1 and NCP2 proteins mutated in this
disease mediate the egress of cholesterol from endo-lysosomal
compartments.23 It has been proposed that NPC1 links to cytoplasmic
sterol transport by members of the oxysterol-binding protein (OSBP)
and its homologues (OSBP-like proteins (OSBPL))22 that constitute a
large family of cytoplasmic lipid binding/transport proteins.24,25
OSBPL11 was found to localize at the Golgi–late endosome interface,
and the OSBPL11–OSBPL9 dimer was suggested to act as an
intracellular lipid sensor or transporter.21,26 Moreover, OSBPL11 was
reported to function in adipogenesis,21,27 and the gene has been
associated with cardiovascular risk factors in obesity.28 NPC1 deﬁcit
causes intracellular lipid accumulation and leukodystrophy,29,30 and
we propose that the moderate accumulation of free cholesterol in the
dermal biopsies of the patients and of sister 2, all homozygous for the
OSBPL11 variant, and the mild accumulation in heterozygous parents
could be because of OSBPL11 deﬁcit. Moreover, knockdown of
OSBPL11 in A431 cells resulted in an increase of ﬁlipin-stainable free
cholesterol, an effect reversed by overexpression of wild-type OSBPL11
but not the c.511C4T variant. In some other diseases that develop as
a result of intracellular lipid deposition, such as certain variants of
neuronal ceroid lipofuscinoses (NCLs), similar cerebellar ataxia and
diffuse demyelinating leukodystrophy as in the present patients are
observed. Thus, in the light of all the available evidence, we ﬁnd it
possible that OSBPL11 c.511C4T may act as a modiﬁer of the patient
phenotype.
In conclusion, the present ﬁndings expand the spectrum of
inherited human leukodystrophies by reporting association of
a homozygous POLR1A variant with such a disease phenotype.
Our genetic, histopathologic, in silico and experimental cell
biological analyses together suggest POLR1A as the gene respon-
sible for the novel disease in the two, severely affected male
patients. We expect that our ﬁndings will facilitate the detection of
new patients with POLR1A mutations. In particular, families
afﬂicted with initial symptoms of ataxia, spasticity, psychomotor
retardation and leukodystrophy could beneﬁt from testing for
mutations in this gene. Our ﬁndings also demonstrate the
challenge in gene identiﬁcation in a novel disease when variants
damaging to protein function in different genes could be exerting
their effects additively or epistatic.
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